Relationship between obstructive sleep apnea and metabolic control and chronic complications in patients with type 2 diabetes mellitus
-
-
关键词:
- 睡眠呼吸暂停,阻塞性 /
- 2型糖尿病 /
- 并发症
Abstract: Obstructive sleep apnea (OSA) is a common sleep apnea disorder. Studies have shown that patients with T2DM have a higher incidence of OSA, and the latter further increases the difficulty of treating diabetes. This paper describes the adverse effects of OSA on type 2 diabetes patients from the perspective of blood sugar, blood lipids, blood pressure and chronic complications of diabetes, to provide recommendations for clinical treatment of OSA.-
Key words:
- sleep apnea, obstructive /
- type 2 diabetes mellitus /
- complications
-
[1] Amin A, Ali A, Altaf QA, et al. Prevalence and Associations of Obstructive Sleep Apnea in South Asians and White Europeans with Type 2 Diabetes: A Cross-Sectional Study[J]. J Clin Sleep Med, 2017, 13(4): 583-589. doi: 10.5664/jcsm.6548
[2] Foster GD, Sanders MH, Millman R, et al. Obstructive sleep apnea among obese patients with type 2 diabetes[J]. Diabetes Care, 2009, 32(6): 1017-1019. doi: 10.2337/dc08-1776
[3] Lam DC, Lui MM, Lam JC, et al. Prevalence and recognition of obstructive sleep apnea in Chinese patients with type 2 diabetes mellitus[J]. Chest, 2010, 138(5): 1101-1107. doi: 10.1378/chest.10-0596
[4] Kendzerska T, Gershon AS, Hawker G, et al. Obstructive sleep apnea and incident diabetes. A historical cohort study[J]. Am J Respir Crit Care Med, 2014, 190(2): 218-225. doi: 10.1164/rccm.201312-2209OC
[5] Tan X, Benedict C. Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication[J]. BMJ Open Diabetes Res Care, 2020, 8: e001702. doi: 10.1136/bmjdrc-2020-001702
[6] West SD, Nicoll DJ, Wallace TM, et al. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes[J]. Thorax, 2007, 62(11): 969-974. doi: 10.1136/thx.2006.074351
[7] Shaw JE, Punjabi NM, Naughton MT, et al. The Effect of Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes[J]. Am J Respir Crit Care Med, 2016, 194(4): 486-492. doi: 10.1164/rccm.201511-2260OC
[8] Martínez-Cerón E, Barquiel B, Bezos AM, et al. Effect of Continuous Positive Airway Pressure on Glycemic Control in Patients with Obstructive Sleep Apnea and Type 2 Diabetes. A Randomized Clinical Trial[J]. Am J Respir Crit Care Med, 2016, 194(4): 476-485. doi: 10.1164/rccm.201510-1942OC
[9] Grimaldi D, Beccuti G, Touma C, et al. Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications[J]. Diabetes Care, 2014, 37(2): 355-463. doi: 10.2337/dc13-0933
[10] Xu H, Liang C, Zou J, et al. Interaction between obstructive sleep apnea and short sleep duration on insulin resistance: a large-scale study: OSA, short sleep duration and insulin resistance[J]. Respir Res, 2020, 21(1): 151. doi: 10.1186/s12931-020-01416-x
[11] Blackman A, Foster GD, Zammit G, et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial[J]. Int J Obes(Lond), 2016, 40(8): 1310-1319. doi: 10.1038/ijo.2016.52
[12] Prasad B, Carley DW, Krishnan JA, et al. Effects of positive airway pressure treatment on clinical measures of hypertension and type 2 diabetes[J]. J Clin Sleep Med, 2012, 8(5): 481-487. doi: 10.5664/jcsm.2136
[13] Myhill PC, Davis WA, Peters KE, et al. Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea[J]. J Clin Endocrinol Metab, 2012, 97(11): 4212-4218. doi: 10.1210/jc.2012-2107
[14] Nadeem R, Singh M, Nida M, et al. Effect of CPAP treatment for obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis[J]. J Clin Sleep Med, 2014, 10(12): 1295-1302. doi: 10.5664/jcsm.4282
[15] Xu H, Yi H, Guan J, et al. Effect of continuous positive airway pressure on lipid profile in patients with obstructive sleep apnea syndrome: a meta-analysis of randomized controlled trials[J]. Atherosclerosis, 2014, 234(2): 446-453. doi: 10.1016/j.atherosclerosis.2014.03.034
[16] Liu Y, Zou J, Qian Y, et al. The association between obesity indices and obstructive sleep apnea is modified by age in a sex-specific manner[J]. Sleep Breath, 2021, 25(1): 189-197. doi: 10.1007/s11325-020-02083-4
[17] Turmel J, Sériès F, Boulet LP, et al. Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study[J]. Int J Cardiol, 2009, 132(2): 203-209. doi: 10.1016/j.ijcard.2007.11.063
[18] Kent BD, Garvey JF, Ryan S, et al. Severity of obstructive sleep apnoea predicts coronary artery plaque burden: a coronary computed tomographic angiography study[J]. Eur Respir J, 2013, 42(5): 1263-1270. doi: 10.1183/09031936.00094812
[19] Kuniyoshi FH, Garcia-Touchard A, Gami AS, et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea[J]. J Am Coll Cardiol, 2008, 52(5): 343-346. doi: 10.1016/j.jacc.2008.04.027
[20] Molnar MZ, Mucsi I, Novak M, et al. Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans[J]. Thorax, 2015, 70(9): 888-895. doi: 10.1136/thoraxjnl-2015-206970
[21] Ou Q, Chen YC, Zhuo SQ, et al. Correction: Continuous Positive Airway Pressure Treatment Reduces Mortality in Elderly Patients with Moderate to Severe Obstructive Severe Sleep Apnea: A Cohort Study[J]. PLoS One, 2018, 13(8): e0201923. doi: 10.1371/journal.pone.0201923
[22] Kokkarinen J. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study[J]. Am J Respir Crit Care Med, 2011, 183(7): 950.
[23] Rice TB, Foster GD, Sanders MH, et al. The relationship between obstructive sleep apnea and self-reported stroke or coronary heart disease in overweight and obese adults with type 2 diabetes mellitus[J]. Sleep, 2012, 35(9): 1293-1298. doi: 10.5665/sleep.2090
[24] Li X, Wang F, Xu H, et al. Interrelationships among common predictors of cardiovascular diseases in patients of OSA: A large-scale observational study[J]. Nutr Metab Cardiovasc Dis, 2020, 30(1): 23-32. doi: 10.1016/j.numecd.2019.07.016
[25] Seicean S, Strohl KP, Seicean A, et al. Sleep disordered breathing as a risk of cardiac events in subjects with diabetes mellitus and normal exercise echocardiographic findings[J]. Am J Cardiol, 2013, 111(8): 1214-1220. doi: 10.1016/j.amjcard.2012.12.053
[26] Zhao X, Li X, Xu H, et al. Relationships between cardiometabolic disorders and obstructive sleep apnea: Implications for cardiovascular disease risk[J]. J Clin Hypertens(Greenwich), 2019, 21(2): 280-290. doi: 10.1111/jch.13473
[27] Boland LL, Shahar E, Wong TY, et al. Sleep-disordered breathing is not associated with the presence of retinal microvascular abnormalities: the Sleep Heart Health Study[J]. Sleep, 2004, 27(3): 467-473. doi: 10.1093/sleep/27.3.467
[28] Leong WB, Jadhakhan F, Taheri S, et al. Effect of obstructive sleep apnoea on diabetic retinopathy and maculopathy: a systematic review and meta-analysis[J]. Diabet Med, 2016, 33(2): 158-168. doi: 10.1111/dme.12817
[29] Mason RH, Kiire CA, Groves DC, et al. Visual improvement following continuous positive airway pressure therapy in diabetic subjects with clinically significant macular oedema and obstructive sleep apnoea: proof of principle study[J]. Respiration, 2012, 84(4): 275-282. doi: 10.1159/000334090
[30] Nesmith BLW, Ihnen M, Schaal S. Poor responders to bevacizumab pharmacotherapy in age-related macular degeneration and in diabetic macular edema demonstrate increased risk for obstructive sleep apnea[J]. Retina, 2014, 34(12): 2423-2430. doi: 10.1097/IAE.0000000000000247
[31] Furukawa S, Saito I, Yamamoto S, et al. Nocturnal intermittent hypoxia as an associated risk factor for microalbuminuria in Japanese patients with type 2 diabetes mellitus[J]. Eur J Endocrinol, 2013, 169(2): 239-246. doi: 10.1530/EJE-13-0086
[32] Full KM, Jackson CL, Rebholz CM, et al. Obstructive Sleep Apnea, Other Sleep Characteristics, and Risk of CKD in the Atherosclerosis Risk in Communities Sleep Heart Health Study[J]. J Am Soc Nephrol, 2020, 31(8): 1859-1869. doi: 10.1681/ASN.2020010024
[33] Tahrani AA, Ali A, Raymond NT, et al. Obstructive sleep apnea and diabetic nephropathy: a cohort study[J]. Diabetes Care, 2013, 36(11): 3718-3725. doi: 10.2337/dc13-0450
[34] Dziewas R, Schilling M, Engel P, et al. Treatment for obstructive sleep apnoea: effect on peripheral nerve function[J]. J Neurol Neurosurg Psychiatry, 2007, 78(3): 295-297.
[35] Tahrani AA, Ali A, Raymond NT, et al. Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes[J]. Am J Respir Crit Care Med, 2012, 186(5): 434-441. doi: 10.1164/rccm.201112-2135OC
[36] Altaf QA, Ali A, Piya MK, et al. The relationship between obstructive sleep apnea and intra-epidermal nerve fiber density, PARP activation and foot ulceration in patients with type 2 diabetes[J]. J Diabetes Complications, 2016, 30(7): 1315-1320. doi: 10.1016/j.jdiacomp.2016.05.025
[37] Vas PR, Ahluwalia R, Manas AB, et al. Undiagnosed severe sleep apnoea and diabetic foot ulceration-a case series based hypothesis: a hitherto under emphasized factor in failure to heal[J]. Diabet Med, 2016, 33(2): e1-4.
计量
- 文章访问数: 1000
- PDF下载数: 238
- 施引文献: 0